ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS

Summary

Double blind RCT aiming to compare the efficacy of Anakinra vs placebo, on top of the standard of care, on restoration of myocardial function at 3 days following treatment initiation, in children admitted for acute myocarditis in intensive care units.

Timeline

Start

2026-02

Primary completion

2029-12

Completion

2029-12

Drugs

Indications